Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Esophageal Neoplasms × olaparib × Clear all

Phase

Phase 2 1 Phase 1/2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 21 Ovarian Neoplasms 13 Neoplasm Metastasis 11 Prostatic Neoplasms 8 Neoplasms 8 Pancreatic Neoplasms 7 Triple Negative Breast Neoplasms 6 Squamous Cell Carcinoma of Head and Neck 4 Advanced Solid Tumors 4 Small Cell Lung Carcinoma 3 Recurrence 3 Head and Neck Neoplasms 3 Fallopian Tube Neoplasms 3 Carcinoma, Squamous Cell 3 Solid Tumors 2 Sarcoma 2 Neuroendocrine Tumors 2 Lymphoma 2 Hodgkin Disease 2 Fanconi Anemia, Complementation Group D1 2 Endometrial Neoplasms 2 Advanced Solid Tumours 2 Advanced Solid Tumor 2 Triple Negative Metastatic Breast Cancer 1 Thymoma 1 Thrombocytosis 1 Solid Tumor 1 Smoking 1 Sarcoma, Ewing 1 Rhabdomyosarcoma 1

Interventions

Paclitaxel 16 Fluorouracil 15 Cisplatin 15 Carboplatin 15 pembrolizumab 14 Irinotecan 11 Radiotherapy 10 Oxaliplatin 10 Cyclophosphamide 10 Capecitabine 9 Leucovorin 8 Radiation 7 Docetaxel 7 fludarabine 6 Gemcitabine 6 Trastuzumab 5 Taxes 5 fludarabine phosphate 4 LY6K protein, human 4 Fluorodeoxyglucose F18 4 Erlotinib Hydrochloride 4 Bevacizumab 4 spartalizumab 3 aldesleukin 3 Surgical Procedures, Operative 3 S 1 (combination) 3 Pemetrexed 3 Nivolumab 3 Drug Therapy 3 zimberelimab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01460888 2013-08-19

ROCOCO

The Christie NHS Foundation Trust

Phase 1 Unknown

Gastrointestinal

Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡